TITLE
Metformin effect on Mycobacterium tuberculosis-infected lung

SUMMARY
Analysis of lung from M. tuberculosis (MT)-infected C57BL/6 mice treated with metformin (MET). The antidiabetic drug MET is an activating agent of adenosine monophosphate-activated protein kinase (AMPK). Results provide insight into the potential use of MET as adjunct antituberculosis therapy.

ORGANISM
Mus musculus

PLATFORM
GPL6887 : Illumina MouseWG-6 v2.0 expression beadchip

CITATIONS
Singhal A, Jie L, Kumar P, Hong GS et al. Metformin as adjunct antituberculosis therapy. Sci Transl Med 2014 Nov 19;6(263):263ra159. PMID:Â  25411472

